Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - GROSS PROFIT
Gross Profit REGN - Regeneron Pharmaceuticals, Inc.
12.2 B
LAST VALUE
7.36%
2 YEAR CAGR
11.55%
5 YEAR CAGR
16.68%
10 YEAR CAGR